scholarly journals Purple patches in an immunocompromised patient: a report of secondary disseminated cutaneous mucormycosis in a man with chronic lymphocytic leukemia

2017 ◽  
Vol 23 (3) ◽  
Author(s):  
Sanjana Iyengar ◽  
Cindy J Chambers ◽  
Jillian W Millsop ◽  
Maxwell A Fung ◽  
Victoria R Sharon
2016 ◽  
Vol 1 (2) ◽  
pp. 48
Author(s):  
Nurul Azira Mohd Shah ◽  
Zeehaida Mohamed ◽  
Nazli Zainuddin ◽  
Siti Suraiya Md Noor

A 36-year-old man with underlying chronic lymphocytic leukemia had left arm swelling for a duration of 3 months. Clinically, the affected arm was swollen, erythematous and tender. Epicoccum nigrum was isolated from the culture of the tissue that was obtained intra-operatively. He was treated and responded to voriconazole therapy. To the best of our knowledge, this is the first case of intramuscular abscess as a result of E. nigrum infection in an immunocompromised patient.


2013 ◽  
Vol 2013 ◽  
pp. 1-4 ◽  
Author(s):  
Rosamaria Fulchini ◽  
Guido Bloemberg ◽  
Katia Boggian

We present a 63-year-old man treated with alemtuzumab for chronic lymphocytic leukemia who developed multiple angiomatous papules and fever. Real-time polymerase chain reaction (RT-PCR) from a skin lesion and blood sample revealedBartonella quintanaas causative agent confirming the diagnosis of bacillary angiomatosis with bacteremia. Treatment with doxycycline, initially in combination with gentamicin, led to complete resolution of the lesions. This case shows the importance of considering bacillary angiomatosis as a rare differential diagnosis of angiomatous lesions in the immunocompromised patient, particularly in chronic lymphocytic leukemia and following lymphocyte depleting treatments as alemtuzumab.


2018 ◽  
Vol 9 (2) ◽  
pp. 62-65 ◽  
Author(s):  
Matthew K. Stein ◽  
Saradasri Karri ◽  
Jackson Reynolds ◽  
Jeff Owsley ◽  
Austin Wise ◽  
...  

Author(s):  
Ida Monrad ◽  
Signe Risgaard Sahlertz ◽  
Stine Sofie Frank Nielsen ◽  
Louise Ørnskov Pedersen ◽  
Mikkel Steen Petersen ◽  
...  

Abstract We report a COVID-19 case with SARS-CoV-2 persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 post diagnosis. Additionally, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.


IDCases ◽  
2021 ◽  
Vol 24 ◽  
pp. e01120
Author(s):  
Katherine R. Sittig ◽  
Leah G. Laageide ◽  
Zaheer Akhtar ◽  
Geoffrey C. Wall ◽  
Sudhir C. Kumar

Sign in / Sign up

Export Citation Format

Share Document